The Screening and Diagnostics of Prostate Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Causes, Screening and Diagnosis".
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 20613
Special Issue Editors
Interests: urologic oncology; prostate cancer; translational research
Special Issue Information
Dear Colleagues,
In this Special Issue dedicated to the screening and diagnostics of prostate cancer various controversies, several studies are presented which illustrate the ongoing improvement and discussion in the field worldwide. The technical progress in imaging with MRI, and PSMA-PET scanning, as well as the new serum and urinary assays, add a number of elements to the process of screening and diagnostic procedures. Multifactorial risk evaluation appears to be basic to make decisions by patients and their physicians. Profs Chris Bangma and Axel Semjonow highlight this dynamic evaluation of thoughts between specialists on early prostate cancer.
Prof. Dr. Chris H. Bangma
Prof. Dr. Axel Semjonow
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prostate cancer
- screening
- diagnosis
- imaging
- biomarkers